References
- World Health Organization. Snakebite envenoming: a strategy for prevention and control. Geneva: World Health Organization; 2019.
- Chippaux JP. Snakebite envenomation turns again into a neglected tropical disease! J Venom Anim Toxins Incl Trop Dis. 2017;23:38.
- Hodgson PS, Davidson TM. Biology and treatment of the mamba snakebite. Wilderness Environ Med. 1996;7:133–145.
- WHO Expert Committee on Biological Standardization. Sixty-seventh report. Geneva: World Health Organization; 2017. (WHO technical report series; no. 1004).
- IUCN Red List [Internet]. Dendroaspis polylepis (Black Mamba). Cambridge (UK): IUCN; 2010.
- Spawls S, Howell K, Hinkel H, et al. Field guide to East African Reptiles. London: Bloomsbury Publishing; 2018.
- National Geographic [Internet]. Black mamba, facts and photos; Washington (DC): National Geographic Partners; n.d. [cited 2020 Dec 16]. Available from: https://www.nationalgeographic.com/animals/reptiles/b/black-mamba/.
- Brittanica [Internet]. Black mamba. Chicago (IL): Encyclopeadia Brittanica.; 2020 [cited 2020 Dec 16]. Available from: https://www.britannica.com/animal/black-mamba
- Blumenthal R, Scholtz PEP, Shuttleworth JL. Black mamba death: venom versus antivenom? Am J Forensic Med Pathol. 2019;40:356–360.
- Závada J, Valenta J, Kopecký O, et al. Black mamba dendroaspis polylepis bite: a case report. Prague Med Rep. 2011;112:298–304.
- Blaylock R. Epidemiology of snakebite in Eshowe, KwaZulu-Natal, South Africa. Toxicon. 2004;43:159–166.
- Christensen PA. Snakebite and the use of antivenom in southern Africa. S Afr Med J. 1981;59:934–938.
- Ainsworth S, Menzies SK, Casewell NR et al. An analysis of preclinical efficacy testing of antivenoms for sub-Saharan Africa: inadequate independent scrutiny and poor-quality reporting are barriers to improving snakebite treatment and management. PLOS Negl Trop Dis. 2020;14(8):e0008579.
- Moran NF, Newman WJ, Theakston DG et al. High incidence of early anaphylactoid reaction to SAIMR polyvalent snake antivenom. Trans R Soc Trop Med Hyg. 1998;92(1):69–70.
- Pantanowitz L, Scott L, Southem J, Schrire L. Development of antivenoms in South Africa. S Afr J Sci. 1998;94:464–469
- African Snakebite Institute [Internet]. Snakebite in southern Africa. Pretoria: African Snakebite Institute; n.d. [cited 2020 Dec 16]. Available from: https://www.africansnakebiteinstitute.com/snakebite/
- Moher D, Liberati A, Tetzlaff J, et al; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006–1012.
- Ouzzani M, Hammady H, Fedorowicz Z, et al. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5:210.
- Moola S, Munn Z, Tufanaru C, et al. Chapter 7: systematic reviews of etiology and risk. In: Aromataris E, Munn Z, editors. JBI manual for evidence synthesis. Adelaide, Australia: JBI; 2020.
- Erulu VE, Okumu MO, Ochola FO, et al. Revered but poorly understood: a case report of Dendroaspis polylepis (Black Mamba) envenomation in Watamu, Malindi Kenya, and a review of the literature. Trop Med Infect Dis. 2018;3:104.
- Schutzbach M, Vonderhagen S, Jäger M. Antiserumtherapie bei Schlangenbiss durch Schwarze Mamba [Antivenom therapy after a black mamba snakebite]. Unfallchirurg. 2016;119:1053–1056.
- Hilligan R. Black mamba bites. A report of 2 cases. S Afr Med J. 1987;72:220–221.
- Naidoo DP, Lockhat HS, Naiker IP. Myocardial infarction after probable black mamba envenomation. A case report. S Afr Med J. 1987;71:388–389.
- Harvey WR. Black mamba envenomation. S Afr Med J. 1985;67:960.
- Shah SARA, Naqvi SS, Abbas MA. Use of neostigmine in black mamba snake bite: a case report. Anaesth Pain Intensive Care. 2016;20:77–79.
- Strover HM. Report on a death from black mamba bite (Dendroaspis polylepis). Cent Afr J Med. 1967;13:185–186.
- Krengel B, Walton J. A case of mamba bite. S Afr Med J. 1967;41:1150–1151.
- Saunders CR. Report on a Black Mamba bite of a medical colleague. Cent Afr J Med. 1980;26:121–122.
- Louw JX. Specific mamba antivenom-report of survival of 2 patients with black mamba bites treated with this serum. S Afr Med J. 1967;41:1175.
- Durrant S, Haagner GV. Venoms and snakebite. J Herp Assoc Afr. 1992;41:46.
- Branch WR, Haagner GV, Morgan DR, et al. Venoms and snakebite. J Herpetol Assoc Africa. 1991;39:28–29.
- Haagner GV. Venoms and snakebite. J Herpetol Assoc Africa. 1990;37:58–60.
- Devlin J, Wood A, Kunisake T, et al. Black mamba envenomation treated with neostigmine. Clin Toxicol. 2012;50:649.
- Visser J, Chapman D. Snake and snakebite. Illustrative cases: front fanged species. Cape Town: Purnell; 1978; p. 115–122.
- Blake DK. Case history of a brown mamba bite. J Herpetol Assoc Rhod. 1960;9(10):17–18.
- Read PH, Foster DI, Broadley DG. Case history of a brown mamba bite in northern Rhodesia. J Herpetol Assoc Rhod. 1959;8:6–7.
- Blaylock RS. Snake bites at Triangle Hospital January 1975 to June 1981. Cent Afr J Med. 1982;28:1–10.
- CastorEDC.com [Internet]. Hoboken (NJ): Castor EDC; 2019. Available from: https://castoredc.com.
- Markwalder K, Koller M. Zwei Fallberichte und Uberlegungen zur Therapie von neurotoxischen Giftschlangenbissen [Mamba bites. 2 case reports and observations on the therapy of neurotoxic poisonous snake bites]. Schweiz Rundsch Med Prax. 1987;76:1281–1284.
- Quarch V, Brander L, Cioccari L. An unexpected case of black mamba (Dendroaspis polylepis) Bite in Switzerland. Case Reports Crit Care. 2017;2017:1–3.
- UC San Diego [Internet]. Immediate first aid for bites by black mamba (Dendroaspis polylepis). San Diego (CA): University of California San Diego.; n.d. [cited 2020 Dec 16]. Available from: http://toxicology.ucsd.edu/Snakebite%20Protocols/Dendroa3.htm
- White J. Bites and stings from venomous animals: a global overview. Ther Drug Monit. 2000;22:65–68.
- Laustsen AH, Lomonte B, Lohse B, et al. Unveiling the nature of black mamba (Dendroaspis polylepis) venom through venomics and antivenom immunoprofiling: identification of key toxin targets for antivenom development. J Proteomics. 2015;119:126–142.
- Barber CM, Isbister GK, Hodgson WC. Alpha neurotoxins. Toxicon. 2013;66:47–58.
- Kumar A, Gupta V. Neurological implications of dendrotoxin: a review. EC Pharmacol Toxicol. 2018;6:469–476.
- Jackson WF. KV channels and the regulation of vascular smooth muscle tone. Microcirculation. 2018;25:e12421.
- Weatherall DJ, Ledingham JGG, Warrell DA. Oxford textbook of medicine. Injuries, envenoming, poisoning, and allergic reactions caused by animals. 3rd ed. Oxford: Oxford University Press; 1996; p. 1126–1139.
- Van Aswegen G, van Rooyen JM, Fourie C, et al. Putative cardiotoxicity of the venoms of three mamba species. Wilderness Environ Med. 1996;7:115–121.
- Mesirca P, Torrente AG, Mangoni ME. Functional role of voltage gated Ca(2+) channels in heart automaticity. Front Physiol. 2015;6:1–13.
- De Silva HA, Ryan NM, de Silva HJ. Adverse reactions to snake antivenom, and their prevention and treatment. Br J Clin Pharmacol. 2016;81:446–452.
- Premawardhena AP, de Silva CE, Fonseka MM, et al. Low dose subcutaneous adrenaline to prevent acute adverse reactions to antivenom serum in people bitten by snakes: randomised, placebo controlled trial. BMJ. 1999;318:1041–1043.
- Kasturiratne A, Wickremasinghe AR, de Silva N et al. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med. 2008;5(11):e218.